Alphamab Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Alphamab Oncology has a total shareholder equity of CN¥1.7B and total debt of CN¥250.0M, which brings its debt-to-equity ratio to 15%. Its total assets and total liabilities are CN¥2.1B and CN¥465.0M respectively.
Key information
15.0%
Debt to equity ratio
CN¥250.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.41b |
| Equity | CN¥1.67b |
| Total liabilities | CN¥465.00m |
| Total assets | CN¥2.14b |
Recent financial health updates
Is Alphamab Oncology (HKG:9966) Using Debt Sensibly?
Oct 04
Is Alphamab Oncology (HKG:9966) A Risky Investment?
May 21Rock star Growth Puts Alphamab Oncology (HKG:9966) In A Position To Use Debt
Oct 05Is Alphamab Oncology (HKG:9966) Using Too Much Debt?
May 05Recent updates
Alphamab Oncology's (HKG:9966) Shares Climb 27% But Its Business Is Yet to Catch Up
May 06Optimistic Investors Push Alphamab Oncology (HKG:9966) Shares Up 27% But Growth Is Lacking
Mar 13Subdued Growth No Barrier To Alphamab Oncology's (HKG:9966) Price
Jan 17Slammed 40% Alphamab Oncology (HKG:9966) Screens Well Here But There Might Be A Catch
May 21Newsflash: Alphamab Oncology (HKG:9966) Analysts Have Been Trimming Their Revenue Forecasts
Mar 01Is Alphamab Oncology (HKG:9966) Using Debt Sensibly?
Oct 04Is Alphamab Oncology (HKG:9966) A Risky Investment?
May 21Rock star Growth Puts Alphamab Oncology (HKG:9966) In A Position To Use Debt
Oct 05Is Alphamab Oncology (HKG:9966) Using Too Much Debt?
May 05How Many Alphamab Oncology (HKG:9966) Shares Have Insiders Sold, In The Last Year?
Feb 09
Should Alphamab Oncology (HKG:9966) Be Disappointed With Their 19% Profit?
Dec 30What Percentage Of Alphamab Oncology (HKG:9966) Shares Do Insiders Own?
Nov 25Financial Position Analysis
Short Term Liabilities: 9966's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥266.8M).
Long Term Liabilities: 9966's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥198.2M).
Debt to Equity History and Analysis
Debt Level: 9966 has more cash than its total debt.
Reducing Debt: 9966 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 9966 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 9966 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 7% each year